Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol., 22 July 2025

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1660020

Correction: A stage IV lung squamous cell cancer patient with brain metastases, high PD-L1 &TMB, achieves pCR and long-term survival after immune-chemotherapy and radical surgery: a case report and literature review

This article is a correction to:

  1. A Stage IV Lung Squamous Cell Cancer Patient with Brain Metastases, High PD-L1 & TMB, Achieves pCR and Long-Term Survival after Immune-Chemotherapy and Radical Surgery: A Case Report and literature review

    1. Read original article
Xiangyu XuXiangyu XuZheng Ma*Zheng Ma*
  • Department of Thoracic Surgery, Chongqing General Hospital, Chongqing University, Chongqing, China

A Correction on
A stage IV lung squamous cell cancer patient with brain metastases, high PD-L1 & TMB, achieves pCR and long-term survival after immune-chemotherapy and radical surgery: a case report and literature review

By Xu X and Ma Z (2025). Front. Immunol. 16:1601125. doi: 10.3389/fimmu.2025.1601125

In the published article, there was an error in affiliation 1. Instead of “Department of Thoracic Surgery, Chongqing People’s Hospital, Chongqing, China”, it should be “Department of Thoracic Surgery, Chongqing General Hospital, Chongqing University, Chongqing, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: non-small cell lung cancer (NSCLC), brain metastasis, programmed cell death ligand 1, tumor mutational burden (TMB), pathological complete response (PCR), circulating tumor DNA (ctDNA)

Citation: Xu X and Ma Z (2025) Correction: A stage IV lung squamous cell cancer patient with brain metastases, high PD-L1 &TMB, achieves pCR and long-term survival after immune-chemotherapy and radical surgery: a case report and literature review. Front. Immunol. 16:1660020. doi: 10.3389/fimmu.2025.1660020

Received: 05 July 2025; Accepted: 10 July 2025;
Published: 22 July 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Xu and Ma. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Zheng Ma, ZHIubWFyQHFxLmNvbQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.